SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Costa Mauricio D) "

Search: WFRF:(Costa Mauricio D)

  • Result 1-4 of 4
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Abbafati, Cristiana, et al. (author)
  • 2020
  • Journal article (peer-reviewed)
  •  
2.
  • Sumaila, U. Rashid, et al. (author)
  • WTO must ban harmful fisheries subsidies
  • 2021
  • In: Science. - : American Association for the Advancement of Science (AAAS). - 0036-8075 .- 1095-9203. ; 374:6567, s. 544-544
  • Journal article (other academic/artistic)
  •  
3.
  • Villa, Luisa L., et al. (author)
  • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
  • 2007
  • In: New England Journal of Medicine. - 0028-4793 .- 1533-4406. ; 356:19, s. 1915-1927
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Human papillomavirus types 16 (HPV-16) and 18 (HPV-18) cause approximately 70% of cervical cancers worldwide. A phase 3 trial was conducted to evaluate a quadrivalent vaccine against HPV types 6, 11, 16, and 18 (HPV-6/11/16/18) for the prevention of high-grade cervical lesions associated with HPV-16 and HPV-18. METHODS: In this randomized, double-blind trial, we assigned 12,167 women between the ages of 15 and 26 years to receive three doses of either HPV-6/11/16/18 vaccine or placebo, administered at day 1, month 2, and month 6. The primary analysis was performed for a per-protocol susceptible population that included 5305 women in the vaccine group and 5260 in the placebo group who had no virologic evidence of infection with HPV-16 or HPV-18 through 1 month after the third dose (month 7). The primary composite end point was cervical intraepithelial neoplasia grade 2 or 3, adenocarcinoma in situ, or cervical cancer related to HPV-16 or HPV-18. RESULTS: Subjects were followed for an average of 3 years after receiving the first dose of vaccine or placebo. Vaccine efficacy for the prevention of the primary composite end point was 98% (95.89% confidence interval [CI], 86 to 100) in the per-protocol susceptible population and 44% (95% CI, 26 to 58) in an intention-to-treat population of all women who had undergone randomization (those with or without previous infection). The estimated vaccine efficacy against all high-grade cervical lesions, regardless of causal HPV type, in this intention-to-treat population was 17% (95% CI, 1 to 31). CONCLUSIONS: In young women who had not been previously infected with HPV-16 or HPV-18, those in the vaccine group had a significantly lower occurrence of high-grade cervical intraepithelial neoplasia related to HPV-16 or HPV-18 than did those in the placebo group.
  •  
4.
  • Kohler, Annegret, et al. (author)
  • Convergent losses of decay mechanisms and rapid turnover of symbiosis genes in mycorrhizal mutualists.
  • 2015
  • In: Nature Genetics. - : Springer Science and Business Media LLC. - 1546-1718 .- 1061-4036. ; 47:4, s. 176-410
  • Journal article (peer-reviewed)abstract
    • To elucidate the genetic bases of mycorrhizal lifestyle evolution, we sequenced new fungal genomes, including 13 ectomycorrhizal (ECM), orchid (ORM) and ericoid (ERM) species, and five saprotrophs, which we analyzed along with other fungal genomes. Ectomycorrhizal fungi have a reduced complement of genes encoding plant cell wall-degrading enzymes (PCWDEs), as compared to their ancestral wood decayers. Nevertheless, they have retained a unique array of PCWDEs, thus suggesting that they possess diverse abilities to decompose lignocellulose. Similar functional categories of nonorthologous genes are induced in symbiosis. Of induced genes, 7-38% are orphan genes, including genes that encode secreted effector-like proteins. Convergent evolution of the mycorrhizal habit in fungi occurred via the repeated evolution of a 'symbiosis toolkit', with reduced numbers of PCWDEs and lineage-specific suites of mycorrhiza-induced genes.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-4 of 4
Type of publication
journal article (4)
Type of content
peer-reviewed (3)
other academic/artistic (1)
Author/Editor
Fanzo, Jessica (2)
Johansson, Lars (1)
Zhang, L. (1)
Paavonen, J (1)
Brown, D. (1)
Ruiz, A. (1)
show more...
Zhou, H. (1)
Allen, B. (1)
Johansson, Tomas (1)
Sulo, Gerhard (1)
Edwards, R (1)
Hassankhani, Hadi (1)
Liu, Yang (1)
Ali, Muhammad (1)
Mitchell, Philip B (1)
McKee, Martin (1)
Madotto, Fabiana (1)
Abolhassani, Hassan (1)
Rezaei, Nima (1)
Castro, Franz (1)
Koul, Parvaiz A. (1)
Weiss, Daniel J. (1)
Ackerman, Ilana N. (1)
Dillner, Joakim (1)
Brenner, Hermann (1)
Mendonca, J. (1)
Barnes, R. (1)
Folke, Carl (1)
Apter, D (1)
Ferrara, Giannina (1)
Salama, Joseph S. (1)
Mullany, Erin C. (1)
Abbafati, Cristiana (1)
Bensenor, Isabela M. (1)
Bernabe, Eduardo (1)
Carrero, Juan J. (1)
Cercy, Kelly M. (1)
Zaki, Maysaa El Saye ... (1)
Esteghamati, Alireza (1)
Esteghamati, Sadaf (1)
Farzadfar, Farshad (1)
Foigt, Nataliya A. (1)
Grosso, Giuseppe (1)
Islami, Farhad (1)
James, Spencer L. (1)
Khader, Yousef Saleh (1)
Kimokoti, Ruth W. (1)
Kumar, G. Anil (1)
Lallukka, Tea (1)
Lotufo, Paulo A. (1)
show less...
University
Lund University (2)
Karolinska Institutet (2)
Uppsala University (1)
Luleå University of Technology (1)
Mid Sweden University (1)
Högskolan Dalarna (1)
show more...
Swedish University of Agricultural Sciences (1)
show less...
Language
English (4)
Research subject (UKÄ/SCB)
Medical and Health Sciences (2)
Natural sciences (1)
Social Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view